Health TrialsbyHealthPanel

Sternocleidomastoid Thickness in Sarcopenia

ConditionSarcopenia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNamik Kemal University

About this trial

In order to prevent sarcopenia in intensive care patients and to guide nutritional therapy, evaluation of muscle thickness with ultrasonography is a modern, simple and non-invasive procedure routinely performed by Anesthesiology and Reanimation specialists. Sarcopenia in intensive care patients has been demonstrated in many studies. It has been studied that routine examination of changes in rectus femoris muscle thickness by ultrasonography is a predictor of sarcopenia. However, the muscles in the neck region, such as the sternocleidomastoid muscle, which are easy to examine, have not been studied very well. There is no study in the literature with the sternocleidomastoid muscle. For this reason, we decided to examine the relationship of sternocleidomastoid muscle thickness with patient characteristics, treatments, feeding route and type, feeding time, length of stay in intensive care unit, as in routine measurements of rectus femoris muscle thickness by ultrasonography.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who are expected to be followed up in the intensive care unit for at least 1 week

Patients over 18 years old

Disqualifiers

Patients under 18 years of age

Head-neck, femur trauma patients

Those with a diagnosis of primary neuromuscular disease

Those who have a condition that prevents imaging in the body parts where ultrasonography is planned

Trial population

Patients who are expected to be followed up in the intensive care unit for at least 1 week in a tertiary university research and education hospital based 11 bed ICU

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Muscle thickness measurement

    Diagnostic test

    Rectus femoris and sternocleidomastoideus muscle thickness will be measured via ultrasonography in admission and on 7th day of admission

Treatment groups

80 Participants
are divided into 1 treatment group
Group A: Muscle thickness measurement1 intervention

Trial outcomes

Primary outcomes

1

Muscle thickness

Rectus femoris and Sternocleidomastoideus muscle thickness change when compared to the value measured at admission to the intensive care unit.

Time frame
1 week

Secondary outcomes

1

Nutrition regime

Nutrition regimes, calorie and protein intake during admission will be saved.

Time frame
1week
2

Nutrition Scores

NRS 2002, NUTRIC scores will be calculated in admission

Time frame
Day 1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Namik Kemal University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: